AI filing briefs · archive

8-K filings in December 2025, explained

619 material Form 8-K filings that 507 companies we cover made with the SEC in December 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

2 of 619 briefs match

newest first · times in ET
XRAYDENTSPLY SIRONA Inc. Dec 31, 4:25 PM ET

Dentsply Sirona amends credit and note agreements, resets leverage covenant limits

Mixed financing Written later 1.012.03

On December 24, 2025, Dentsply Sirona obtained lender consent and signed amendments to its JPMorgan-agented revolving credit facility and three note purchase agreements. The changes replace the prior leverage covenants with new Total Leverage and Senior Leverage Ratio limits, cap efficiency-initiative EBITDA addbacks at $75 million through December 31, 2026, and add a new covenant restricting Restricted Payments, subject to exceptions.

  • Amendments dated December 24, 2025 cover the revolving credit facility with JPMorgan Chase Bank, N.A. as administrative agent and three note purchase agreements.
  • Total Leverage Ratio cap is 4.25 to 1.00 for quarters ending December 31, 2025 through June 30, 2026, stepping down to 3.50 to 1.00 from September 30, 2027.
  • Senior Leverage Ratio cap is 3.25 to 1.00 through June 30, 2026, stepping down to 2.50 to 1.00 from September 30, 2027.
  • EBITDA addbacks for efficiency initiatives are capped at $75 million in the aggregate for quarters ending December 31, 2025 through December 31, 2026.
Read the filing on SEC.gov ↗
MATWMATTHEWS INTERNATIONAL CORP Dec 31, 12:55 PM ET

Matthews Closes $232.1 Million Sale of Warehouse Automation Business to Duravant

Neutral m&a Written later 2.017.01

Matthews International completed the sale of its Warehouse Automation business, Matthews Automation Solutions, LLC, and certain related assets to Duravant LLC on December 31, 2025. Total consideration was $232.1 million, including $225.4 million in cash and the assumption of certain liabilities, and the company plans to use the net proceeds to significantly reduce debt. The company said its strategic alternatives review remains ongoing.

  • Sale closed December 31, 2025, under an Equity Purchase Agreement dated November 12, 2025
  • Total consideration of $232.1 million: $225.4 million cash plus assumed liabilities
  • The business generated $72 million in sales in fiscal 2025
  • Net proceeds, after taxes and transaction costs, will be used to significantly reduce outstanding debt
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.